Bookmark Menu

  • HARARE, February 22, 2016 –A vaginal ring containing an antiretroviral (ARV) drug called dapivirine that women inserted into their genital tract and used for a month at a time was safe and helped protect against HIV in a large-scale clinical trial involving more than 2,600 women in Zimbabwe, Malawi, Uganda and South Africa, researchers who […]

  • University of Zimbabwe Pro Vice Chancellor (Academic), Professor Chipo Dyanda toured five UZ-UCSF Clinical Research sites (CRSs) on 12/March/2015 to familiarise herself with the research activities and infrastructure established to support these activities. The five CRSs are Spilhaus, St Mary’s, Zengeza, Seke South and Seke North. UZ-UCSF Executive Director, Professor Z Mike Chirenje led the UZ-UCSF delegation […]

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

UZ-UCSF Collaborative Research Programme

The University of Zimbabwe-University of California San Francisco Collaborative Research Program (UZ-UCSF) was established in 1994 to implement high quality science addressing HIV prevention and therapy; its aim is to control Zimbabwe’s HIV/AIDS epidemic and contribute to global policy as a center of excellence at the University of Zimbabwe College of Health Sciences (UZCHS) in collaboration with UCSF and its partner institutions.

Over the last 20 years, the program has developed a governance structure built on principles of inclusiveness and collaboration of scientific, community, and administrative functions, coupled with efficiency and transparency in resource allocation. A wide range of research collaborations between the institutions have been developed, whereby faculty and staff work closely together in the development and execution of new innovative research. We are pushing our already effective governance structures to establish more open mechanisms for generating new research initiatives in both public and private sectors.

More about UZ-UCSF Our Research

UZ-UCSF News

Sharon Maxwell Community Impact Award

Sharon Maxwell Community Impact Award

July 7th, 2016

In 2015 the community created an award recognizing the diverse and expanding contributions of ACTG CAB members outside the network community commitments. The Sharon Maxwell Community Impact Award honors herRead More

Dapivirine vaginal ring helped protect women against HIV in ASPIRE Phase III trial

Dapivirine vaginal ring helped protect women against HIV in ASPIRE Phase III trial

February 22nd, 2016

HARARE, February 22, 2016 –A vaginal ring containing an antiretroviral (ARV) drug called dapivirine that women inserted into their genital tract and used for a month at a time wasRead More